Loading insider details...
Beta
Latest Form 4 (Aug 13, 2026): Sale of 10,000 XENE shares, $640.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 13, 2026 | Xenon Pharmaceuticals Inc. (XENE) | Sale | 10,000 | $640.6K |
| Jun 4, 2026 | Xenon Pharmaceuticals Inc. (XENE) | Exercise/Conversion | 2,645 | n/a |
| May 14, 2026 | Xenon Pharmaceuticals Inc. (XENE) | Exercise/Conversion | 3,500 | $25.8K |
| Jun 6, 2025 | Xenon Pharmaceuticals Inc. (XENE) | Sale | 3 | $91.44 |
| May 16, 2025 | Xenon Pharmaceuticals Inc. (XENE) | Exercise/Conversion | 5,144 | $64.7K |
| Jun 5, 2024 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 15,542 | n/a |
| Jun 4, 2024 | Fusion Pharmaceuticals Inc. (FUSN) | Disposition to Issuer | 56,400 | n/a |
| Mar 8, 2024 | Xenon Pharmaceuticals Inc. (XENE) | Sale | 1,000 | $46.5K |
| Jun 2, 2023 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 18,475 | n/a |
| Jun 29, 2022 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 18,000 | n/a |